Candesartan HCT Zentiva 8/12.5mg, Tabletten - 100 Swissmedic Key 62321014 Registration Holder Helvepharm AG Name Candesartan HCT Zentiva 8/12.5mg, Tabletten Date of registration 30.01.2012 Original/Generic Generic Introduction of Sequence 30.01.2012 ATC-Classification Candesartan and Diuretics (C09DA06) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 02.07.20. Show package size 100 Index Therapeuticus (Swissmedic) 02.07.20. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 25.59 Limitation No Deductible 10 % Consumer price 44.20 Feedback FB GTIN 7680623210142 Medication Code Synthetika Pharmacode Disponibility
Composition candesartanum cilexetilum 8 mg, hydrochlorothiazidum 12.5 mg, maydis amylum, lactosum monohydricum 117.3 mg, triethylis citras, hydroxypropylcellulosum, carmellosum natricum conexum 4 mg corresp. magnesii stearas, pro compresso, natrium 0.36 mg. Packungsbestandteile Galenic Form Tablets Active Agent Dose Candesartanum Cilexetil 8 mg Hydrochlorothiazide 12.5 mg
BAG: Active Agent Dose Candesartanum Cilexetil 8 mg Hydrochlorothiazide 12.5 mg
Inactive agents Dose Carmellosum Natricum Conexum 4 mg Hydroxypropylcellulosum Lactose Monohydrate 117.3 mg Maydis Amylum Sodium 0.36 mg Pro Compresso Triethylis Citras
Source Data was imported : 06.07.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
